QUEBEC CITY--(BUSINESS WIRE)--ITR Laboratories Canada Inc., a global provider of preclinical services, is pleased to announce new scientific leadership with the arrival of Abbas Fotovati, Ph.D., D.V.M., as senior veterinary scientist. In this role, Fotovati will be responsible for the company’s experimental and developmental veterinary services.
Fotovati joins ITR from the University of British Columbia where he served on the faculty of the Department of Oncology and the Department of Experimental Medicine and Medical Genetics.
He has also held academic, veterinary and pharmaceutical research positions in Japan, North America and the Middle East.
With more than 25 years of experience, Fotovati is an accomplished scientist and published researcher in animal models on cancer, osteoporosis, wound healing, rheumatoid arthritis, angiogenesis and lipid metabolism, as well as in translational medicine and molecular therapeutics of novel drugs.
In addition to his expertise in animal modeling, which has granted him eligibility for the board of American College of Laboratory Animal Medicine (ACLAM), he is a molecular and development biologist with extensive knowledge of new areas in this field, including stem cell biology.
“We are pleased that Abbas has chosen to contribute to our ongoing success,” said Ginette Bain, senior vice president at ITR. “His broad preclinical knowledge and combination of industry experience and academic research will enable ITR to provide innovative scientific service and specialized surgical expertise to our clients.”
About ITR Laboratories Canada
ITR Laboratories Canada Inc. provides preclinical testing services for pharmaceutical and biotechnology industries worldwide. As a CRO with extensive experience, ITR provides clients with valuable input and best practices, which ultimately help them maximize the value of their investment.